UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000024664
Receipt No. R000028369
Scientific Title Japanese lung cancer registry study: Prospective registry database of patients with malignant mesothelioma
Date of disclosure of the study information 2017/04/03
Last modified on 2018/01/30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Japanese lung cancer registry study: Prospective registry database of patients with malignant mesothelioma
Acronym Japanese lung cancer registry study: Prospective registry on malignant mesothelioma treatment
Scientific Title Japanese lung cancer registry study: Prospective registry database of patients with malignant mesothelioma
Scientific Title:Acronym Japanese lung cancer registry study: Prospective registry on malignant mesothelioma treatment
Region
Japan

Condition
Condition Malignant mesothelioma
Classification by specialty
Pneumology Chest surgery Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to assess the clinicopathological features of new cases with malignant mesothelioma diagnosed from 1st April 2017 to 31th March 2018 in Japan.
Basic objectives2 Others
Basic objectives -Others Participation in the prospective database project in International Mesothelioma Interest Group (IMIG)
Trial characteristics_1 Others
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes A nationwide prospective registry study on the prognosis and clinicopathological profiles of malignant mesothelioma diagnosed from 1st April 2017 to 31th March 2018 in Japan.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria All new cases of malignant mesothelioma diagnosed from 1st April 2017 to 31th March 2019 in Japan.
Key exclusion criteria Patients who refused to participate in this study
Target sample size 300

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Ichiro Yoshino
Organization Chiba University Graduate School of Medicine
Division name General Thoracic Surgery
Zip code
Address 1-8-1, Inohana, Chuo-ku, Chiba-city, Chiba, Japan
TEL 043-222-7171
Email 1royoshino@gmail.com

Public contact
Name of contact person
1st name
Middle name
Last name Meinoshin Okumura
Organization Osaka University Graduate School of Medicine
Division name General Thoracic Surgery
Zip code
Address 2-2-L5, Yamadaoka, Suita, Osaka, Japan
TEL 06-6879-3152
Homepage URL https://haigan-touroku.jp/
Email haigan@thoracic.med.osaka-u.ac.jp

Sponsor
Institute Japanese Joint Committee of Lung Cancer Registry
Institute
Department

Funding Source
Organization Japanese Joint Committee of Lung Cancer Registry
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 全国の大学医学部附属病院および地域の基幹施設で参加を希望する施設

Other administrative information
Date of disclosure of the study information
2017 Year 04 Month 03 Day

Related information
URL releasing protocol https://haigan-touroku.jp/
Publication of results Unpublished

Result
URL related to results and publications https://haigan-touroku.jp/
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2016 Year 10 Month 11 Day
Date of IRB
Anticipated trial start date
2017 Year 04 Month 01 Day
Last follow-up date
2021 Year 04 Month 30 Day
Date of closure to data entry
2024 Year 04 Month 30 Day
Date trial data considered complete
2026 Year 03 Month 31 Day
Date analysis concluded
2028 Year 03 Month 31 Day

Other
Other related information We monitor all new cases of malignant mesothelioma diagnosed from 1st April 2017 to 31th March 2019 in Japan. Using clinical data from the registry, treatment outcome will be analyzed.

Management information
Registered date
2016 Year 10 Month 31 Day
Last modified on
2018 Year 01 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028369

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.